| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K78574327 |
| PharmacoGx | BRD-K78574327 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PEX5L | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-05 |
| mRNA | RSPO4 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0001 |
| mRNA | GTF2I | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | C1orf61 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0001 |
| mRNA | TIGD3 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0001 |
| mRNA | PHLDB1 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.0001 |
| mRNA | FAM117B | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0001 |
| mRNA | E2F3 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | HRAS | CTRPv2 | pan-cancer | AAC | 0.3 | 0.0001 |
| mRNA | IRAK2 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
